ECONOMIC BURDEN OF TYPE 2 DIABETES IN PERU: A COST-OF-ILLNESS STUDY VALUING COST DIFFERENCES ASSOCIATED WITH THE LEVEL OF GLYCEMIC CONTROL

被引:0
|
作者
Seinfeld, J. [1 ]
Sobrevilla, A. [1 ]
Rosales, M. L. [1 ]
Ibanez, M. [1 ]
Ruiz, D. [1 ]
Penny, E. [1 ]
Londono, S. [2 ]
机构
[1] Videnza Consultores, Lima, Peru
[2] Sanofi, Bogota, Colombia
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE18
引用
收藏
页码:S53 / S53
页数:1
相关论文
共 50 条
  • [41] The economic burden of inherited retinal disease in Singapore: a prevalence-based cost-of-illness study
    Junxing Chay
    Rachael Wei Chao Tang
    Tien-En Tan
    Choi Mun Chan
    Ranjana Mathur
    Brian J. H. Lee
    Hiok Hong Chan
    Shaun S. K. P. Sim
    Saadia Farooqui
    Kelvin Y. C. Teo
    Eva K. Fenwick
    Ecosse L. Lamoureux
    Chui Ming Gemmy Cheung
    Beau J. Fenner
    Eye, 2023, 37 : 3827 - 3833
  • [42] Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness Study
    K. Ray Chaudhuri
    Jean-Philippe Azulay
    Per Odin
    Susanna Lindvall
    Josefa Domingos
    Ali Alobaidi
    Prasanna L. Kandukuri
    Vivek S. Chaudhari
    Juan Carlos Parra
    Toru Yamazaki
    Julia Oddsdottir
    Jack Wright
    Pablo Martinez-Martin
    Drugs - Real World Outcomes, 2024, 11 : 1 - 11
  • [43] Economic Burden of Parkinson's Disease: A Multinational, Real-World, Cost-of-Illness Study
    Chaudhuri, K. Ray
    Azulay, Jean-Philippe
    Odin, Per
    Lindvall, Susanna
    Domingos, Josefa
    Alobaidi, Ali
    Kandukuri, Prasanna L.
    Chaudhari, Vivek S.
    Parra, Juan Carlos
    Yamazaki, Toru
    Oddsdottir, Julia
    Wright, Jack
    Martinez-Martin, Pablo
    DRUGS-REAL WORLD OUTCOMES, 2024, 11 (01) : 1 - 11
  • [44] The economic burden of inherited retinal disease in Singapore: a prevalence-based cost-of-illness study
    Chay, Junxing
    Tang, Rachael Wei Chao
    Tan, Tien-En
    Chan, Choi Mun
    Mathur, Ranjana
    Lee, Brian J. H.
    Chan, Hiok Hong
    Sim, Shaun S. K. P.
    Farooqui, Saadia
    Teo, Kelvin Y. C.
    Fenwick, Eva K.
    Lamoureux, Ecosse L.
    Cheung, Chui Ming Gemmy
    Fenner, Beau J.
    EYE, 2023, 37 (18) : 3827 - 3833
  • [45] The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study
    Henderson, Raymond Hugo
    French, Declan
    Maughan, Timothy
    Adams, Richard
    Allemani, Claudia
    Minicozzi, Pamela
    Coleman, Michel P.
    McFerran, Ethna
    Sullivan, Richard
    Lawler, Mark
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (09): : 709 - 722
  • [46] THE CLINICAL AND ECONOMIC BURDEN OF OBSTRUCTIVE SLEEP APNEA IN ADULTS: A COST-OF-ILLNESS ANALYSIS
    Armeni, P.
    Borsoi, L.
    Donin, G.
    Costa, F.
    Ferini-Strambi, L.
    VALUE IN HEALTH, 2019, 22 : S742 - S742
  • [47] Economic costs of obesity in Thailand: a retrospective cost-of-illness study
    Paiboon Pitayatienanan
    Rukmanee Butchon
    Jomkwan Yothasamut
    Wichai Aekplakorn
    Yot Teerawattananon
    Naeti Suksomboon
    Montarat Thavorncharoensap
    BMC Health Services Research, 14
  • [48] Economic costs of obesity in Thailand: a retrospective cost-of-illness study
    Pitayatienanan, Paiboon
    Butchon, Rukmanee
    Yothasamut, Jomkwan
    Aekplakorn, Wichai
    Teerawattananon, Yot
    Suksomboon, Naeti
    Thavorncharoensap, Montarat
    BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [49] Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study
    Nguyen Tu Dang Le
    Luyen Dinh Pham
    Trung Quang Vo
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2017, 10 : 363 - 374
  • [50] COST-OF-ILLNESS IN ADULTS WITH DIABETES MELLITUS TYPE I IN THE RUSSIAN FEDERATION
    Bessonova, T.
    Keleynova, E.
    Ratushnyak, S.
    Ratushnyak, E.
    VALUE IN HEALTH, 2022, 25 (01) : S63 - S63